Andrea Freeman

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Paul G. Richardson, Robert Schlossman, Edie Weller et al. · Blood · 2002 · 804 citations · Full text

Medicine, Immunology, Pharmacology +12

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Paul G. Richardson, Emily Blood, Constantine S. Mitsiades et al. · Blood · 2006 · 522 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

T-cell–depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

Edwin P. Alyea, Edie Weller, Robert Schlossman et al. · Blood · 2001 · 205 citations · Full text

Medicine, Hematology, Immunology +15

Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity

Paul G. Richardson, Robert Schlossman, Sundar Jagannath et al. · Mayo Clinic Proceedings · 2004 · 127 citations

Medicine, Hematology, Oncology +16

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma

KC Anderson, Janet Andersen, RJ Soiffer et al. · Blood · 1993 · 101 citations · Full text

Medicine, Hematology, Oncology +12